{
    "clinical_study": {
        "@rank": "95723", 
        "arm_group": [
            {
                "arm_group_label": "Abrreviated MgSO4 protocol", 
                "arm_group_type": "Experimental", 
                "description": "-\tCategory B : 80  patients given abbreviated doses of MgSO4 (4 grams of MgSO4 on 250 ml ringer solution over 4 hours every 4 hours by IV drip only for 12 hours) in the postpartum period."
            }, 
            {
                "arm_group_label": "No maintenance protocol", 
                "arm_group_type": "Experimental", 
                "description": "-\tCategory C : 80 patients who will take only loading dose of MgSO4 (6 grams of MgSO4 on 250 ml ringer solutions over 20 minutes) with no postpartum maintenance sulfate"
            }, 
            {
                "arm_group_label": "standard MgSO4 protocol", 
                "arm_group_type": "Active Comparator", 
                "description": "-\tCategory A : 80 patients given full dose of maintenance MgSO4 (4 grams of MgSO4 on 250 ml ringer solution over 4 hours every 4 hours by IV drip for 24 hours) in the postpartum period."
            }
        ], 
        "brief_summary": {
            "textblock": "there is a standard magnesium sulphate protocol and newer protocols for pre-eclampsia, we\n      need to make a trial to find the best protocol"
        }, 
        "brief_title": "New Magnesium Sulphate Protocol for Pre-eclampsia", 
        "completion_date": {
            "#text": "April 2014", 
            "@type": "Actual"
        }, 
        "condition": "Pre-eclampsia", 
        "condition_browse": {
            "mesh_term": [
                "Eclampsia", 
                "Pre-Eclampsia"
            ]
        }, 
        "detailed_description": {
            "textblock": "The aim of our study is to assess the comparative effects of three regimens for the\n      administration of magnesium sulfate when used for the care of women with severe\n      pre-eclampsia.\n\n      The study will include 240 pregnant women presenting to the casualty unit with criteria of\n      severe preeclampsia in the form of one of the criteria:-\n\n        -  Systolic blood pressure \u2265 160.\n\n        -  Diastolic blood pressure \u2265 110.\n\n        -  Proteinuria > +2 by dip stick.\n\n        -  Presence of alarming symptoms (headache, visual disturbance, epigastric pain, vaginal\n           bleeding).\n\n        -  Fetal growth restriction (IUGR).\n\n      After obtaining an informed consent the patients will be subjected to the following:\n\n        -  Careful history taking including age, parity, gestational age.\n\n        -  Complete physical examination and assessment of the blood pressure.\n\n        -  Urine analysis by dipstick.\n\n        -  All women will take initial MgSO4 (6 grams of MgSO4 on 250 ml ringer solutions over 20\n           minutes by IV drip) .\n\n      Using Random Number Table, the sample size will be divided into three categories:-\n\n        -  Category A : 80 patients given full dose of maintenance MgSO4 (4 grams of MgSO4 on 250\n           ml ringer solution over 4 hours every 4 hours by IV drip for 24 hours) in the\n           postpartum period.\n\n        -  Category B : 80  patients given abbreviated doses of MgSO4 (4 grams of MgSO4 on 250 ml\n           ringer solution over 4 hours every 4 hours by IV drip only for 12 hours) in the\n           postpartum period.\n\n        -  Category C : 80 patients who will take only loading dose of MgSO4 (6 grams of MgSO4 on\n           250 ml ringer solutions over 20 minutes) with no postpartum maintenance sulfate.\n\n      Inclusion criteria:\n\n        -  Pregnant females \u226520 weeks of gestation.\n\n        -  Pregnant females with criteria of severe pre-eclampsia.\n\n        -  Single or multi-fetal  pregnancy.\n\n        -  Primigravida or Multigravida.\n\n      Exclusion criteria:\n\n        -  Pregnant females < 20 weeks gestation.\n\n        -  Pregnant females with history of epilepsy.\n\n        -  Pregnant females with diabetes.\n\n        -  Pregnant females with chronic hypertension.\n\n        -  Pregnant females with renal disease."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Pregnant females \u226520 weeks of gestation.\n\n          -  Pregnant females with criteria of severe pre-eclampsia.\n\n          -  Single or multi-fetal  pregnancy.\n\n          -  Primigravida or Multigravida.\n\n        Exclusion Criteria:\n\n          -  Pregnant females < 20 weeks gestation.\n\n          -  Pregnant females with history of epilepsy.\n\n          -  Pregnant females with diabetes.\n\n          -  Pregnant females with chronic hypertension.\n\n          -  Pregnant females with renal disease."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "42 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "240", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 1, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01846156", 
            "org_study_id": "52103", 
            "secondary_id": "52013"
        }, 
        "intervention": {
            "arm_group_label": [
                "Abrreviated MgSO4 protocol", 
                "No maintenance protocol", 
                "standard MgSO4 protocol"
            ], 
            "description": "A randomized controlled study that compare three regimens for administration of MgSO4 used for the cases of severe pre-eclampsia that will be performed in the Obstetrics & Gynecology Department, Kasr Al-Ainy Hospital, Cairo University", 
            "intervention_name": "MgSO4", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Magnesium Sulfate"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "convulsion rate", 
        "lastchanged_date": "April 7, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Cairo", 
                    "country": "Egypt", 
                    "zip": "12311"
                }, 
                "name": "Kasr Alainy hospital"
            }
        }, 
        "location_countries": {
            "country": "Egypt"
        }, 
        "number_of_arms": "3", 
        "official_title": "The Best Magnesium Sulphate Protocol for Severe Pre-eclampsia : A Randomized Controlled Trial", 
        "overall_official": {
            "affiliation": "Cairo University", 
            "last_name": "Waleed El-khayat, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Egypt: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "convulsion", 
            "measure": "convulsion rate", 
            "safety_issue": "Yes", 
            "time_frame": "1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01846156"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Cairo University", 
            "investigator_full_name": "Waleed El-khayat", 
            "investigator_title": "Assistant Professor of Obstetrics & Gynecology", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "ICU admission", 
            "measure": "ICU admission", 
            "safety_issue": "Yes", 
            "time_frame": "1 year"
        }, 
        "source": "Cairo University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Cairo University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}